ETF Managers Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $148K | Buy |
+9,004
| New | +$148K | ﹤0.01% | 609 |
|
|
2022
Q4 | – | Sell |
-12,846
| Closed | -$167K | – | 677 |
|
|
2022
Q3 | $167K | Sell |
12,846
-128
| -1% | -$1.66K | 0.01% | 616 |
|
|
2022
Q2 | $180K | Sell |
12,974
-2,686
| -17% | -$37.3K | 0.01% | 655 |
|
|
2022
Q1 | $226K | Sell |
15,660
-12,757
| -45% | -$184K | ﹤0.01% | 595 |
|
|
2021
Q4 | $386K | Sell |
28,417
-1,648
| -5% | -$22.4K | 0.01% | 563 |
|
|
2021
Q3 | $490K | Buy |
30,065
+8,362
| +39% | +$136K | 0.01% | 539 |
|
|
2021
Q2 | $365K | Buy |
21,703
+930
| +4% | +$15.6K | 0.01% | 575 |
|
|
2021
Q1 | $381K | Buy |
20,773
+405
| +2% | +$7.43K | 0.01% | 549 |
|
|
2020
Q4 | $370K | Buy |
20,368
+1,071
| +6% | +$19.5K | 0.01% | 483 |
|
|
2020
Q3 | $350K | Buy |
19,297
+12,052
| +166% | +$219K | 0.01% | 397 |
|
|
2020
Q2 | $131K | Buy |
+7,245
| New | +$131K | ﹤0.01% | 578 |
|